Vladimir Ignatchenko

This paper uses N-glycoproteomics to analyze patient-derived xenografts, identifies FAT2 as a therapeutic target for head and neck cancers, and validates its role in tumor growth and CAR T cell activity.

This study identifies SLC7A1 and arginine metabolism as a therapeutic vulnerability in high-grade serous ovarian cancer through surface proteomics and functional analysis.

The paper quantifies secreted and extracellular vesicle (EV) urinary proteomes in men with and without prostate cancer, showing their stability and utility in distinguishing malignant from benign lesions.